Single-cell and bulk transcriptomics identifies a tumor-specific CD36<sup>+</sup> cancer-associated fibroblast subpopulation in colorectal cancer

Jin Wang; Ming-Jia Xi; Qing Lu; Bi-Han Xia; Yu-Zhi Liu; Jin-Lin Yang

doi:10.1002/cac2.12506

Cancer Communications ›› 2024, Vol. 44 ›› Issue (4) : 495-498. DOI: 10.1002/cac2.12506

LETTER TO THE EDITOR

Single-cell and bulk transcriptomics identifies a tumor-specific CD36⁺ cancer-associated fibroblast subpopulation in colorectal cancer

Jin Wang¹^,² ,
Ming-Jia Xi¹^,² ,
Qing Lu¹^,² ,
Bi-Han Xia¹^,² ,
Yu-Zhi Liu¹^,² ,
Jin-Lin Yang¹^,²

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Jin Wang, Ming-Jia Xi, Qing Lu, Bi-Han Xia, Yu-Zhi Liu, Jin-Lin Yang. Single-cell and bulk transcriptomics identifies a tumor-specific CD36⁺ cancer-associated fibroblast subpopulation in colorectal cancer. Cancer Communications, 2024, 44(4): 495‒498 https://doi.org/10.1002/cac2.12506

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174-186.

[2]	Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793-807.

[3]	Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 2023;9(1):25.

[4]	Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670-691.

[5]	Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, et al. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 2021;12(4):328.

[6]	Wang H, Franco F, Tsui YC, Xie X, Trefny MP, Zappasodi R, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298-308.

[7]	Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33(5):1001-1012.e5.

[8]	Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13(1):5782.

[9]	Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41-45.

[10]	Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, et al. CD36 inhibits beta-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10(1):3981.